Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt
· Delayed Price · Currency is EGP 1.340
-0.040 (-2.90%)
At close: Mar 9, 2026
EGX:MCRO Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Market Capitalization | 787 | 650 | 1,323 | 1,682 | 1,870 | - | Upgrade
|
| Market Cap Growth | -31.68% | -50.86% | -21.36% | -10.06% | - | - | Upgrade
|
| Enterprise Value | 945 | 817 | 1,475 | 1,815 | 1,944 | - | Upgrade
|
| Last Close Price | 1.38 | 1.14 | 0.51 | 0.64 | 0.69 | - | Upgrade
|
| PE Ratio | 6.90 | 5.62 | - | - | 10.76 | - | Upgrade
|
| Forward PE | - | 10.07 | 10.07 | 10.07 | 10.07 | - | Upgrade
|
| PS Ratio | 0.88 | 0.73 | 2.54 | 3.20 | 2.56 | - | Upgrade
|
| PB Ratio | 4.06 | 3.35 | 16.94 | 17.83 | 4.04 | - | Upgrade
|
| P/TBV Ratio | 4.71 | 3.89 | 25.84 | 25.10 | 4.56 | - | Upgrade
|
| P/FCF Ratio | 6.64 | 5.49 | - | - | 14.43 | - | Upgrade
|
| P/OCF Ratio | 4.89 | 4.04 | - | - | 13.86 | - | Upgrade
|
| PEG Ratio | - | 0.42 | 0.42 | 0.42 | 0.42 | - | Upgrade
|
| EV/Sales Ratio | 1.06 | 0.91 | 2.84 | 3.45 | 2.66 | - | Upgrade
|
| EV/EBITDA Ratio | 6.19 | 5.82 | 88.83 | - | 8.17 | - | Upgrade
|
| EV/EBIT Ratio | 6.97 | 6.03 | 122.57 | - | 8.30 | - | Upgrade
|
| EV/FCF Ratio | 7.97 | 6.89 | - | - | 15.00 | - | Upgrade
|
| Debt / Equity Ratio | 1.72 | 1.72 | 4.05 | 2.40 | 0.44 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 2.19 | 2.19 | 11.06 | - | 0.83 | 0.47 | Upgrade
|
| Debt / FCF Ratio | 2.81 | 2.81 | - | - | 1.58 | 2.20 | Upgrade
|
| Net Debt / Equity Ratio | 0.81 | 0.81 | 3.25 | 1.60 | 0.04 | 0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.12 | 1.12 | 15.30 | -0.86 | 0.08 | 0.18 | Upgrade
|
| Net Debt / FCF Ratio | 1.33 | 1.33 | -2.93 | -3.39 | 0.14 | 0.84 | Upgrade
|
| Asset Turnover | 1.29 | 1.29 | 0.92 | 0.77 | 1.02 | 1.21 | Upgrade
|
| Inventory Turnover | 2.81 | 2.81 | 1.61 | 1.64 | 1.64 | 2.15 | Upgrade
|
| Quick Ratio | 0.47 | 0.47 | 0.36 | 0.29 | 1.18 | 1.19 | Upgrade
|
| Current Ratio | 1.35 | 1.35 | 1.35 | 1.08 | 2.00 | 2.31 | Upgrade
|
| Return on Equity (ROE) | 85.15% | 85.15% | -44.13% | -97.85% | 42.37% | 48.77% | Upgrade
|
| Return on Assets (ROA) | 12.16% | 12.16% | 1.33% | -16.72% | 20.53% | 25.81% | Upgrade
|
| Return on Invested Capital (ROIC) | 36.77% | 37.66% | 4.17% | -50.24% | 40.92% | 47.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 43.10% | 43.10% | 5.20% | -152.40% | 48.50% | 54.90% | Upgrade
|
| Earnings Yield | 14.71% | 17.80% | -2.88% | -16.21% | 9.29% | - | Upgrade
|
| FCF Yield | 15.06% | 18.23% | -6.56% | -2.64% | 6.93% | - | Upgrade
|
| Dividend Yield | - | - | - | - | 15.40% | - | Upgrade
|
| Payout Ratio | - | - | - | - | 23.01% | 31.65% | Upgrade
|
| Buyback Yield / Dilution | - | - | -1.12% | 1.46% | 0.88% | - | Upgrade
|
| Total Shareholder Return | - | - | -1.12% | 1.46% | 16.29% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.